A new aspect of the pharmacological and physiological significance of the aromatase/estrogen system

Folia Pharmacologica Japonica

Volumn 112, Issue 1, 1998, Pages 51-58

  Harada, Nobuhiro ^a  

^a FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Alternative exons 1; Aromarase; Estrogen; Estrogen receptor; Tissue specific expression

Indexed keywords

AROMATASE; ESTROGEN; ESTROGEN RECEPTOR; SEX HORMONE;

BRAIN; ESTROGEN SYNTHESIS; EXON; FETUS LIVER; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; OVARY; PLACENTA; PROMOTER REGION; PROSTATE; REGULATOR GENE; REPRODUCTION; REVIEW; SKIN FIBROBLAST; TESTIS; TISSUE SPECIFICITY;

EID: 0031814226     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.112.51     Document Type: Review

References (30)

1. Harada N: Cloning of a complete cDNA encoding human aromatase; immunochemical identification and sequence analysis. Biochem Biophys Res Commun 156, 725-732 (1988)
2. Means GD, Kilgore MW, Mahendroo MS, Mendelson CR and Simpson ER: Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues. Mol Endocrinol 5, 2005-2013 (1991)
3. Harada N, Utsumi T and Takagi Y: Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis. Proc Natl Acad Sci USA 90, 11312-11316 (1993)
4. Santen RJ, Martel J, Hoagland M, Naftolin F, Roa L, Harada N, Hafer L, Zaino R and Santner SJ: Stromal spindle cells contain aromatase in human breast tumors. J Clin Endocrinol Metab 79, 627-632 (1994)
5. Sasano H, Kaga K, Satao S, Yajima A, Nagura H and Harada N: Aromatase cytochrome P450 gene expression in endometrial carcinoma. Br J Cancer 74, 1541-1544 (1996)
6. Harada N, Ota H, Yoshimura N, Katsuyama T and Takagi Y: Localized aberrant expression of cytochrome P450 aromatase in primary and metastatic malignant tumors of human liver. J Clin Endocrinol Metab 83, 687-702 (1998)
7. Kaga K, Sasano H, Harada N, Ozaki M, Sato S and Yajima A: Aromatase in human common epithelial ovarian neoplasms. Am J Pathol 149, 45-51 (1996)
8. Hiramatsu M, Maehara I, Ozaki M, Harada N, Orikasa S and Sasano H: Aromatase in hyperplasia and carcinoma of the human prostate. Prostate 31, 118-124 (1997)
9. Harada N, Yamada K, Saito K, Kibe N, Dohmae S and Takagi Y: Structural characterization of the human estrogen synthetase (aromatase) gene. Biochem Biophys Res Commun 166, 365-372 (1990)
10. Bone 11, 47-54 (1997)
11. Utsumi T, Harada N, Maruta M and Takagi Y: Presence of alternatively spliced transcripts of aromatase gene in human breast cancer. J Clin Endocrinol Metab 81, 2344-2349 (1996)
12. Yamada K, Harada N, Honda S and Takagi Y: Regulation of placenta-specific expression of the aromatase cytochrome P-450 gene. J Biol Chem 270, 25064-25069 (1995)
13. Nishizuka M and Arai Y: Sexual dimorphism in synaptic organization in the amygdala and its dependence on neonatal hormone environment. Brain Res 212, 31-38 (1981)
14. MacLusky NJ and Naftolin F: Sexual differentiation of the central nervous system. Science 211, 1294-1303 (1981)
15. McDonald PG and Doughty C: Inhibition of androgen-sterilization in the female rat by administration of an anti-oestrogen. J Endocrinol 55, 455-456 (1972)
16. McEwen BS, Lieberburg I, Chatptal C and Krey LC: Aromatization: important for sexual differentiation of the neonatal rat brain. Horm Behav 9, 249-263 (1977)
17. Balthazart J, Foidart A and Harada N: Immunocytochemical localization of aromatase in the brain. Brain Res 524, 327-333 (1990)
18. Harada N, Abe-Dohmae S, Loeffen R, Foidart A and Balthazart J: Synergism between androgens and estrogens in the induction of aromatase and its messenger RNA in the brain. Brain Res 622, 243-256 (1993)
19. Matsumoto A and Arai Y: Sexual dimorphism in 'wiring pattern' in the hypothalamic arcuate nucleus and its modification by neonatal hormonal environment. Brain Res 190, 238-242 (1980)
20. Stephenson J: More evidence links NSAID, estrogen use with reduced Alzheimer risk. JAMA 275, 1389-1390 (1996)
21. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H and Mayeux R: Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348, 429-432 (1996)
22. Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE and Hennekens CH: A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 313, 1044-1049 (1985)
23. Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PW and Anderson JJ: The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 329, 1141-1146 (1993)
24. Sasano H, Uzuki M, Sawai T, Nagura H, Matsunaga G, Kashimoto O and Harada N: Aromatase in human bone tissue. J Bone Miner Res 12, 1416-1423 (1997)
25. Horowitz MC: Cytokines and estrogen in bone: anti-osteoporotic effects. Science 260, 626-627 (1993)
26. Farhat MY, Lavigne MC and Ramwell PW: The vascular protective effects of estrogen. FASEB J 10, 615-624 (1996)
27. Hou Q and Gorski J: Estrogen receptor and progesterone receptor genes are expressed differentially in mouse embryos during preimplantation development. Proc Natl Acad Sci USA 90, 9460-9464 (1993)
28. Bulun SE and Simpson ER: Competitive reverse transcription-polymerase chain reaction analysis indicates that levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age. J Clin Endocrinol Metab 78, 428-432 (1994)
29. Mullis PE, Yoshimura N, Kuhlmann B, Lippuner K, Jaeger P and Harada N: Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, muticystic ovaries, and bone densitometry in childhood. J Clin Endocrinol Metab 82, 1739-1745 (1997)